<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The roles in brain development </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies have shown the association between OTX2 and OTX1 with anaplastic and <z:e sem="disease" ids="C1511789" disease_type="Disease or Syndrome" abbrv="">desmoplastic</z:e> <z:hpo ids='HP_0002885'>medulloblastomas</z:hpo>, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we investigated OTX1 and OTX2 expression in Non-Hodgkin <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> (NHL) and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A combination of semiquantitative RT-PCR, Western blot, and immunohistochemical analyses was used to measure OTX1 and OTX2 levels in <z:mpath ids='MPATH_458'>normal</z:mpath> lymphoid tissues and in 184 tumor specimens representative of various forms of NHL and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>OTX1 expression was activated in 94% of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, in <z:hpo ids='HP_0000001'>all</z:hpo> Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and in 90% of high-grade follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>OTX1 was undetectable in precursor-B lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, and in most marginal zone and mantle cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>OTX2 was undetectable in <z:hpo ids='HP_0000001'>all</z:hpo> analyzed <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Analysis of OTX1 expression in <z:mpath ids='MPATH_458'>normal</z:mpath> lymphoid tissues identified a subset of resting germinal center (GC) B cells lacking PAX5 and BCL6 and expressing cytoplasmic IgG and syndecan </plain></SENT>
<SENT sid="8" pm="."><plain>About 50% of OTX1(+) GC B cells co-expressed CD10 and CD20 </plain></SENT>
<SENT sid="9" pm="."><plain>This study identifies OTX1 as a molecular marker for high-grade GC-derived NHL and suggests an involvement of this transcription factor in B-cell <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, OTX1 expression in a subset of <z:mpath ids='MPATH_458'>normal</z:mpath> GC B cells carrying plasma cell markers suggests its possible contribution to terminal B-cell differentiation </plain></SENT>
</text></document>